Maria J Valkema, Manon C W Spaander, Jurjen J Boonstra, Jolanda M van Dieren, Wouter L Hazen, G Willemien Erkelens, I Lisanne Holster, Andries van der Linden, Klaas van der Linde, Liekele E Oostenbrug, Rutger Quispel, Erik J Schoon, Peter D Siersema, Michail Doukas, Ben M Eyck, Berend J van der Wilk, Pieter C van der Sluis, Bas P L Wijnhoven, Sjoerd M Lagarde, J Jan B van Lanschot
BACKGROUND: Active surveillance is being investigated as an alternative to standard surgery after neoadjuvant chemoradiotherapy for oesophageal cancer. It is unknown whether dysphagia persists or develops when the oesophagus is preserved after neoadjuvant chemoradiotherapy. The aim of this study was to assess the prevalence and severity of dysphagia during active surveillance in patients with an ongoing response. METHODS: Patients who underwent active surveillance were identified from the Surgery As Needed for Oesophageal cancer ('SANO') trial...
September 6, 2023: British Journal of Surgery